ESR1 and breast cancer: Altogether, these results advocate for a contributing role of ER signaling in the regulation of MHC I expression in estrogen-dependent BC (Figure 1), which may consequently impact the recognition and subsequent elimination of BC cells by CD8+ cytotoxic T lymphocytes.